Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for functional capacity in heart failure with preserved ejection fraction
2011-001674-25Phase 2Terminated
- Sponsor
- Francisco J. González VÃlchez
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Change in total distance walked in the six-minute walk test. Started Mar 2012; status: terminated.
02
Drugs
sildenafil
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on 2011-001674-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001674-25.